Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Enteral Zinc to Improve Growth in Infants at Risk for Bronchopulmonary Dysplasia

NCT03532555 is registered in ClinicalTrials.gov with University of Utah as lead sponsor.

NCT NCT03532555
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03532555 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Enteral Zinc to Improve Growth in Infants at Risk for Bronchopulmonary Dysplasia
Lead sponsor
University of Utah
Phase
Not applicable
Overall status
Terminated
Start date
March 22, 2018
Completion date
August 25, 2022
Enrollment
37 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bronchopulmonary dysplasia, growth failure, infant,premature